Making the Case for Biomarkers in Cancer Treatment
Read how melanoma survivor T.J. Sharpe’s experience on two clinical trials highlights the need for biomarkers to predict benefit from immunotherapy.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1127224/syndication
- Syndication ID: 18394
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Wednesday, December 19, 2018 at 06:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:41 PM
Embed Code Snippet
To get the embed code snippet please Login.
